BlackRock’s Impact BioMedical IBO Stock Holding History
Bought
Maintained
Sold
Other funds holding IBO
BlackRock's IBO Position: Q3 2026 in Review
BlackRock reduced its Impact BioMedical (IBO) stake by 2.8% in Q3 2026, selling an estimated $3.36K and leaving 20,024 shares worth $112K. The position accounts for ﹤0.01% of the portfolio, ranked #5088.
BlackRock first reported a position in IBO in Q1 2025 and has held it in 7 quarters since. The position peaked at $168K in Q3 2025. 19 funds tracked by Wall St. Rank hold IBO as of Q3 2026.
- BlackRock held 20,024 shares of Impact BioMedical worth $112K as of Q3 2026.
- BlackRock sold 574 Impact BioMedical shares in Q3 2026, an estimated $3.36K.
- Impact BioMedical made up ﹤0.01% of BlackRock's portfolio in Q3 2026, its #5088 holding.
- BlackRock first reported a position in Impact BioMedical in Q1 2025 and has held it in 7 quarters since.
- BlackRock's Impact BioMedical position peaked at $168K in Q3 2025.
- 19 funds tracked by Wall St. Rank held Impact BioMedical as of Q3 2026.
Based on BlackRock's 13F filing for Q3 2026, filed 13 Nov 2026.